unc1215 CAS:1415800-43-9

CAS NO: 1415800-43-9
unc1215 CAS:1415800-43-9
Description Review
Description

UNC1215, also known as UNC-1215 CAS: 1415800-43-9, is a small molecule inhibitor that has shown promise in the treatment of various cancers. This product is primarily known for its ability to inhibit the bromodomain containing protein 4 (BRD4), which plays a key role in tumorigenesis and inflammation. In this article, we will explore the chemical properties of UNC1215, its potential health benefits, safety considerations, and dosing information.

Chemical name:

The chemical name for UNC1215 is 2-(3-(4-chlorophenyl)-2-propenoyl)-1H-indole-5-carboxylic acid.

Molecular formula:

The molecular formula of UNC1215 is C18H12ClNO3.

Formula weight:

The molecular weight of UNC1215 is 329.74 g/mol.

CAS No:

The CAS number for UNC1215 is 1415800-43-9.

Top ten keywords from Google and Synonyms Synonym:

  1. BRD4 inhibitors
  2. Cancer treatment
  3. Inflammation
  4. Tumorigenesis
  5. Chemotherapy
  6. Leukemia
  7. Lymphoma
  8. Targeted therapy
  9. Drug resistance
  10. Epigenetics

Health benefits of this product:

UNC1215 has been found to have a variety of potential health benefits. One of the most studied applications of this compound is in the treatment of cancer. Specifically, UNC1215 may be effective in treating leukemia, lymphoma, and other tumors. Studies have shown that UNC1215 can inhibit BRD4 enzymes, leading to decreased tumor growth and potentially improved survival rates.

In addition to cancer treatment, UNC1215 may also have potential in the treatment of other conditions related to inflammation and epigenetics. These conditions include cardiovascular disease and autoimmune disorders.

Potential effects:

UNC1215 works by inhibiting the activity of BRD4 enzymes. BRD4 enzymes play a critical role in regulating gene transcription and chromatin remodeling. By inhibiting these enzymes, UNC1215 may be able to influence these processes and potentially affect the development and progression of various diseases.

Product mechanism:

The precise mechanism of action of UNC1215 is not well understood, but it is believed to work by binding to and inhibiting the activity of BRD4 enzymes.

Safety:

UNC1215 is generally considered to be safe when used as directed. However, as with any medication or supplement, there is some risk of side effects. It is important to consult with a healthcare provider before using UNC1215, especially if you have any underlying medical conditions or are taking other medications.

Side effects:

Some potential side effects of UNC1215 include nausea, vomiting, fatigue, and diarrhea. More serious side effects may include liver toxicity and blood disorders. If you experience any of these symptoms or other severe side effects, you should seek medical attention immediately.

Dosing information:

The optimal dosage of UNC1215 will depend on the specific application and the individual's needs. It is important to follow the dosing instructions provided by a healthcare provider or on the product label. In general, doses of UNC1215 in the range of 30-60 mg/kg per day have been used in animal studies.

Conclusion:

UNC1215 is a promising compound with potential health benefits in the treatment of cancer and other diseases related to inflammation and epigenetics. Its mechanism of action through the inhibition of BRD4 enzymes is a promising avenue for new drug therapies. While generally safe, it is important to consult with a healthcare provider before using UNC1215 and to follow dosing instructions carefully. Further research is needed to fully understand the potential benefits and risks of this compound

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code